CMC-1 Replacement Arthroplasty Versus Trapeziectomy
Thumb carpometacarpal (CMC-1) osteoarthritis is a common condition causing pain and disability, particularly among middle-aged and older women. When non-operative treatment fails, surgery is indicated. In Sweden, trapeziectomy (TE), with or without tendon-based adjuncts, is the standard procedure and recommended in the National Care Program introduced in 2022. However, total joint arthroplasty (TJA) has gained popularity because of reports of faster recovery and improved early function, although concerns remain regarding complications, durability, and cost. Comparative studies are therefore needed.
The aim of this study is to compare patient-reported outcomes after dual-mobility TJA versus TE, with or without tendon-based adjuncts, for CMC-1 osteoarthritis using data from the Swedish Hand Surgery Quality Register (HAKIR). To reduce bias in observational data, the study will emulate a hypothetical randomized target trial.
This registry-based cohort study will include adults aged 45 years or older undergoing primary surgery for CMC-1 osteoarthritis. Patients with previous CMC-1 surgery, bilateral procedures, inflammatory joint disease, or extensive missing baseline data will be excluded. Baseline is defined as the date of surgery, and patients will be followed using patient-reported outcome measures collected preoperatively and at 3 and 12 months.
The primary outcome is change in pain on load measured with the HQ-8 questionnaire at 12 months. Secondary outcomes include pain at 3 months, low pain levels at 12 months, other HQ-8 domains, QuickDASH score, patient satisfaction, grip and pinch strength, thumb range of motion, time to reoperation, and postoperative complications.
Potential confounders will be identified using a directed acyclic graph (DAG). Measured confounders include age, sex, surgical centre, calendar year, baseline pain, baseline function, and smoking. Unmeasured factors such as surgeon preference, patient preference, and disease severity not captured in the registry may still cause residual confounding.
Primary analyses will use linear mixed-effects regression to compare adjusted mean pain outcomes between groups at 12 months while accounting for clustering by patient and centre. Secondary outcomes will be analysed using ordinal logistic regression, Cox proportional hazards regression, and logistic regression. Missing data will be handled using multiple imputation, and sensitivity analyses using inverse probability weighting will assess the impact of reoperations and selection bias
Přehled studie
Postavení
Typ studie
Zápis (Odhadovaný)
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
adults aged ≥45 years with a diagnosis of CMC-1 osteoarthritis (ICD-10 code M18) who have failed non-operative treatment and are scheduled for primary CMC-1 surgery.
Exclusion Criteria:
- Bilateral CMC-1 surgery or other simultaneous hand interventions
- Previous CMC-1 surgery on the affected hand
- Inflammatory joint disease affecting the hands (e.g., rheumatoid arthritis, systemic lupus erythematosus)
- 30% missing baseline (preoperative) variables
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
|---|
|
Adults diagnosed with and operated for CMC1 OA (ICD-10 M18*)
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change from baseline to 12 months in pain on load motion measured with the HAKIR questionnaire.
Časové okno: Baseline and 12 months postoperatively
|
Pain on load motion assessed using the HQ-8 patient-reported outcome questionnaire.
Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
|
Baseline and 12 months postoperatively
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change from baseline to 12 months in pain on unloaded motion measured with the HAKIR questionnaire
Časové okno: Baseline and 12 months after surgery
|
Pain on unloaded motion assessed using the HQ-8 patient-reported outcome questionnaire.
Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
|
Baseline and 12 months after surgery
|
|
Change from baseline to 12 months in pain at rest measured with the HQ-8 questionnaire
Časové okno: Baseline and 12 months postoperatively
|
Pain at rest assessed using the HQ-8 patient-reported outcome questionnaire.
Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
|
Baseline and 12 months postoperatively
|
|
Change from baseline to 12 months in stiffness measured with the HQ-8 questionnaire
Časové okno: Baseline and 12 months postoperatively
|
Stiffness assessed using the HQ-8 patient-reported outcome questionnaire.
Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
|
Baseline and 12 months postoperatively
|
|
Change from baseline to 12 months in weakness measured with the HQ-8 questionnaire
Časové okno: Baseline and 12 months postoperatively
|
Weakness assessed using the HQ-8 patient-reported outcome questionnaire.
Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
|
Baseline and 12 months postoperatively
|
|
Change from baseline to 12 months in activities of daily living measured with the HQ-8 questionnaire
Časové okno: Baseline and 12 months postoperatively
|
Activities of daily living assessed using the HQ-8 patient-reported outcome questionnaire.
Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
|
Baseline and 12 months postoperatively
|
|
Change from baseline to 12 months in Quick Disabilities of Arm, Shoulder and Hand Questionnaire (Quick DASH)
Časové okno: Baseline and 12 months postoperatively
|
Upper extremity disability and symptoms assessed using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire.
Scores range from 0 to 100, where higher scores indicate greater disability and worse upper extremity function.
|
Baseline and 12 months postoperatively
|
|
Change in key pinch strength
Časové okno: Baseline and 12 months postoperatively
|
kg
|
Baseline and 12 months postoperatively
|
|
Change in grip strength
Časové okno: Baseline and 12 months postoperatively
|
jamar (kg)
|
Baseline and 12 months postoperatively
|
|
Change in thumb radial abduction
Časové okno: Baseline and 12 months postoperatively
|
radial abduction (degrees)
|
Baseline and 12 months postoperatively
|
|
Change in thumb plamar abduction
Časové okno: From preoperatively to 12 months postoperatively
|
palmar abduction (degrees)
|
From preoperatively to 12 months postoperatively
|
|
Time to first reoperation* of the index hand
Časové okno: primary horizon: 12 months; secondary: maximum available follow-up
|
primary horizon: 12 months; secondary: maximum available follow-up
|
|
|
Risk of any (non-reoperation) complication within 12 months
Časové okno: within 12 months after surgery
|
occurrence of any registered postoperative complication of the index hand recorded in HAKIR
|
within 12 months after surgery
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- HAKIRcmc1
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .